Circulating galectin-3 level association with cardiovascular risk factors during peritoneal dialysis.

Xuerui YangJun YangYoujia ZengLing PengXingzheng LiuJinying MoTaifen WangYutong YaoYihou ZhengGaofeng Song

Published in: Clinical and experimental nephrology (2024)

Gal-3 was strongly associated with BNP, GDF-15, IVST and LVMI in patients undergoing PD treatment. Prospective studies should be carried out to determine whether Gal-3 can be a promising biomarker in predicting increased risk of adverse cardiovascular events in PD patients.

Keyphrases

end stage renal disease
peritoneal dialysis
cardiovascular events
cardiovascular risk factors
chronic kidney disease
patients undergoing
cardiovascular disease
coronary artery disease
ejection fraction
metabolic syndrome
prognostic factors
adverse drug